Melanoma patients who took a specific type of beta blocker while receiving immunotherapy lived longer than patients who received immunotherapy alone, according to researchers.
Melanoma patients who took a specific type of beta blocker while receiving immunotherapy lived longer than patients who received immunotherapy alone, according to researchers.